Information about Epics Therapeutics
My details
*
*
*
{{translate('company_activity_bron_' + bron)}}
NACE Description
{{activiteit.code}} {{activiteit.description}}

Epics Therapeutics (SA)

BE 0690.759.071

Rue Adrienne Bolland 47, 6041 Charleroi
Company information
Status
Active
Enterprise number
BE0690.759.071
VAT liability
Yes
Established
20-02-2018
Last balance sheet year
2023
Company size
Medium-sized 32,4 FTE
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Epics Therapeutics
{{translate("download")}}

Publications in the Belgian Official Journal from Epics Therapeutics

Date Publication
13-11-2024 Resignations, Appointments (FR)
14-08-2024 Articles of Association (Translation, Coordination, Other Modifications, …) - Capital, Shares - Resignations, Appointments (FR)
16-07-2024 Capital, Shares - Resignations, Appointments (FR)
22-05-2023 Resignations, Appointments (FR)
30-12-2022 Resignations, Appointments (FR)

Frequently asked questions

What is the VAT number of Epics Therapeutics?
The VAT number of Epics Therapeutics is BE0690759071.
When was Epics Therapeutics founded?
Epics Therapeutics was founded on 20-02-2018.
What is the address of Epics Therapeutics?
The current registered office of Epics Therapeutics is located at Rue Adrienne Bolland 47, 6041 Charleroi.
When was the last time Epics Therapeutics filed their annual financial statements?
The most recent financial statements of Epics Therapeutics were filed on 09-07-2024. You can view them here.
How many employees does Epics Therapeutics have?
There are 32,4 FTEs working at Epics Therapeutics according to the staff figures in the most recent financial statements.
What is the annual turnover of Epics Therapeutics?
At the time of its most recent financial statements, Epics Therapeutics did not publish any turnover figures. Epics Therapeutics reported a gross margin of €3,355,980.75.

Sources